Brief: Cero Therapeutics Holdings Inc - Receives Nasdaq Notice For Bid Price Non-Compliance
13/06/2025 22:21
June 13 (Reuters) - CERo Therapeutics Holdings Inc CERO.O: CERO THERAPEUTICS HOLDINGS INC - RECEIVES NASDAQ NOTICE FOR BID PRICE NON-COMPLIANCE - SEC FILING Further company coverage: CERO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List